BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 932 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $709,836 | -0.3% | 17,372 | +24.9% | 0.22% | -9.7% |
| Q4 2022 | $712,130 | +46.8% | 13,908 | +55.1% | 0.25% | +44.2% |
| Q3 2022 | $485,000 | +8.0% | 8,969 | +29.0% | 0.17% | +11.7% |
| Q2 2022 | $449,000 | -12.5% | 6,954 | +5.4% | 0.15% | +0.7% |
| Q1 2022 | $513,000 | -7.4% | 6,598 | +2.6% | 0.15% | +8.5% |
| Q4 2021 | $554,000 | +10.6% | 6,429 | +3.5% | 0.14% | +16.5% |
| Q3 2021 | $501,000 | +15.7% | 6,213 | +15.9% | 0.12% | +23.5% |
| Q2 2021 | $433,000 | -34.5% | 5,361 | -31.4% | 0.10% | -46.2% |
| Q1 2021 | $661,000 | +8162.5% | 7,820 | +7566.7% | 0.18% | +5966.7% |
| Q1 2019 | $8,000 | +14.3% | 102 | 0.0% | 0.00% | -40.0% |
| Q4 2018 | $7,000 | -77.4% | 102 | -74.6% | 0.01% | -54.5% |
| Q3 2018 | $31,000 | +3.3% | 401 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $30,000 | +15.4% | 401 | 0.0% | 0.01% | +22.2% |
| Q1 2018 | $26,000 | 0.0% | 401 | 0.0% | 0.01% | -10.0% |
| Q4 2017 | $26,000 | +4.0% | 401 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $25,000 | +4.2% | 401 | 0.0% | 0.01% | -9.1% |
| Q2 2017 | $24,000 | +14.3% | 401 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $21,000 | +16.7% | 401 | 0.0% | 0.01% | +22.2% |
| Q4 2016 | $18,000 | – | 401 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |